The aim of the study is to examine and understand the clinical thresholds for interpreting the predictions of Trauma Induced Coagulopathy (TIC) risk prediction model that has been developed and validated in previous studies (Perkins et al., 2021, Yet et al., 2014). These risk predictions involve uncertainty regarding the true underlying state of coagulopathy.

The questionnaire will be done electronically and online. Your participation in the research must be entirely voluntary. In the study, no identity or institution identifying information is requested from you. Your answers will be kept completely confidential and evaluated only by the researchers. The information to be obtained from the participants will be evaluated collectively and used in scientific publications.

The questionnaire does not contain questions that may cause discomfort in the participants. However, during participation, for any reason, if you feel uncomfortable, you are free to quit at any time.

The data collected from the participants will be kept completely confidential and the data and identity information will not be matched in any way. In addition, only researchers will be able to access the collected data. The results of this research may be used in scientific and professional publications or for educational purposes, but the identity of the participants will be kept confidential.

The questionnaire will take approximately 15-20 minutes. As a part of this survey, the participants will be shown predictive performances of pairs of TIC risk prediction models operated at different risk thresholds. Real or simulated patient information or data has not been used in this study.

We would like to thank you in advance for your participation in this study. For any questions or further information about the study, you can contact Rojda Toraman (rojdatoraman[at]gmail[dot]net), Giles Goatly (giles[dot]goatly[at]nhs[dot]net) or Barbaros Yet (byet[at]metu[dot]edu[dot]tr).

Ethics approval was obtained by METU Human Research Ethics Committee (XXX-XXXX-XXX).